Opinion statement
Optimal treatment of a brain abscess requires early clinical suspicion, and the diagnosis is usually made by identification of the abscess on contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI). The immediate first step is to reduce the potentially life-threatening brain mass (abscess and surrounding cerebral edema) and secure the diagnosis with culture specimens. This is usually accomplished by reducing the increased intracranial pressure (ICP) through surgical aspiration with or without drainage of the abscess pus. The surgical procedure chosen depends on several factors, including the location and type of abscess, multiplicity, and the medical condition of the patient. In addition, dexamethasone and hyperventilation may be required if brain herniation is imminent. The dexamethasone dose should be reduced as soon as the ICP is reduced because steroid administration may retard abscess capsule formation and decrease antibiotic concentrations within the abscess cavity. Antibiotic therapy should be started as soon as the diagnosis is made. Penicillin G or third-generation cephalosporins plus metronidazole are commonly given to treat both anaerobic and aerobic bacteria. The initial choice of antibiotic will vary on the basis of the suspected source of the brain organisms, which is most often either contiguous spread from a sinus or mastoid infection or hematogenous spread from a pulmonary, gastrointestinal, cardiac, or dental infection. Isolation and determination of the antibiotic sensitivities of the organism from abscess pus allow definitive antibiotic therapy. Patients should be managed in an intensive care unit. Phenytoin is often given to prevent seizures, which could further elevate the ICP. The duration of antimicrobial treatment is 4 to 8 weeks, during which time the patient should be monitored clinically and with repeated neuroimaging studies to ensure abscess resolution.
Article PDF
Similar content being viewed by others
References and Recommended Reading
Nicolosi A, Hauser WA, Musicco M, Kurland LT: Incidence and prognosis of brain abscess in a defined population: Olmsted County, Minnesota, 1935–1981. Neuroepidemiology 1991, 10(3):122–131.
Yen PT, Chan ST, Huang TS: Brain abscess: with special reference to otolaryngologic sources of infection. Otolaryngol Head Neck Surg 1995, 113:15–22. This is a careful review of brain abscesses of sinus, ear, mastoid, and dental origin.
Wong TT, Lee LS, Wang HS, et al.: Brain abscesses in children—a cooperative study of 83 cases. Child Nerv Syst 1989, 5:19–24.
Renier D, Hirsch E, Hirsch JF: Brain abscesses in neonates. A study of 30 cases. J Neurosurg 1988, 69:877–882.
Schliamser SE, Backman K, Norrby SR: Intracranial abscesses in adults: an analysis of 54 consecutive cases. Scand J Infect Dis 1988, 20:1–9.
Mathisen GE, Johnson JP: Brain abscess. Clin Infect Dis 1997, 25:763–781. Current review of clinical, neuroimaging, and therapeutic aspects of brain abscesses.
Seydoux CH, Francioli P: Bacterial brain abscesses: factors influencing mortality and sequelae. Clin Infect Dis 1992, 15:394–401.
Nielsen H, Harmsen A, Gyldensted C: Cerebral abscess: a long-term follow-up. Acta Neurol Scand 1983, 67:330–337.
Kagawa M, Takeshita M, Yato S, Kitamura K: Brain abscess in congenital cyanotic heart disease. J Neurosurg 1983, 58:913–917.
Chun CH, Johnson JD, Hofstetter M, Raff MJ: Brain abscess: a study of 45 consecutive cases. Medicine 1986, 65:415–431.
Davis LE, Kornfeld M: Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. Eur Neurol 1991, 31:229–240.
Britt RH, Enzmann DR: Clinical stages of human brain abscesses on serial CT scans after contrast infusion. J Neurosurg 1983, 59:972–989.
Wispelwey B, Scheld WM: Brain abscess. In Principles and Practice of Infectious Diseases, n 4. Edited by Mandell GL, Bennett JE, Dolin R. New York: Churchill Livingstone; 1995:887–897. An excellent current review of the pathogenesis, etiologic agents, and clinical manifestations of a brain abscess.
Yang SY, Zhao CS: Review of 140 patients with brain abscess. Surg Neurol 1993, 39:290–296. Current review of cases occurring in the People’s Republic of China.
Brogden RN, Spencer CM: Cefotaxime: a reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections. Drugs 1997, 53:483–510.
Brogden RN, Ward A: Ceftriaxone: a reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. Drugs 1988, 35:604–645.
Sjolin J, Erikksson N, Arneborn P, et al.: Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans. Antimicrob Agents Chemother 1991, 35:2606–2610.
Sjolin J, Lija A, Eriksson N, et al.: Treatment of brain abscess with cefotaxime and metronidazole: prospective study on 15 consecutive patients. Clin Infect Dis 1993, 17:857–863.
Todd PA, Brogden RN: Cefotaxime: an update of its pharmacology and therapeutic use. Drugs 1990, 40:608–651.
Falagas ME, Gorbach SL: Clindamycin and metronidazole. Med Clin North Am 1995, 79:845–867.
Rosenblum ML, Mampalam TJ, Pons VG: Controversies in management of brain abscesses. Clin Neurosurg 1986, 33:603–632. A good review of the controversies regarding surgical therapy plus antibiotics compared with antibiotics alone. Also considers the pros and cons of corticosteroid use.
Laborde G, Klimek L, Harders A, Gilsbach J: Frameless stereotactic drainage of intracranial abscess. Surg Neurol 1993, 40:16–21. A good review of CT-guided sterotaxy for brain abscess.
Lo WD, Wolny A, Boesel C: Blood-brain barrier permeability in staphylococcal cerebritis and early abscess. J Neurosurg 1994, 80:897–905.
Weisberg LA: Nonsurgical management of focal intracranial infection. Neurology 1981, 31:575–580.
Mamelak AN, Mampalam TJ, Obana WG, Rosenblum ML: Improved management of multiple brain abscesses: a combined surgical and medical approach. Neurosurgery 1995, 36:76–86.
Chacko AG, Chandy MJ: Diagnostic and staged stereotactic aspiration of multiple bihemispheric pyogenic brain abscesses. Surg Neurol 1997, 48:278–283.
Nadvi SS, Parboosing R, Rikus van Dellen J: Cerebellar abscess: the significance of cerebrospinal fluid diversion. Neurosurgery 1997, 41:61–67.
Katz RW, Davis LE: Reye’s syndrome. In Neurocritical Care. Edited by Hacke W, Hanley DR, Einhaupl K, et al. Berlin: Springer-Verlag; 1994:860–865.
Kim SH, Chang KH, Song IC, et al.: Brain abscess and brain tumor: discrimination with in vivo H-1 MR spectroscopy. Radiology 1997, 204:239–245.
Ebisu T, Tanaka C, Umeda M, et al.: Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 1996, 14:1113–1116.
Dev R, Gupta RK, Poptani H, et al.: Role of in vivo proton magnetic resonance spectroscopy in the diagnosis and management of brain abscesses. Neurosurgery 1998, 42:37–43.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davis, L.E., Baldwin, N.G. Brain abscess. Curr Treat Options Neurol 1, 157–166 (1999). https://doi.org/10.1007/s11940-999-0015-7
Issue Date:
DOI: https://doi.org/10.1007/s11940-999-0015-7